免疫療法におけるマクロファージを標的とする:CAR-マクロファージの上昇
1Department of Host Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN 38103, USA.
International journal of molecular sciences
|February 13, 2026
まとめ
化学抗原受容体 (CAR) - マクロファージ (CAR-M) 治療は,マクロファージの天然の腫瘍標的化能力を活用して,固体腫瘍に対して有望であることが示されています. このレビューでは,CAR-Mの開発,進歩,強化されたがん免疫療法の課題について検討しています.
科学分野:
- 免疫学 免疫学とは
- 腫瘍学 腫瘍学
- バイオテクノロジー バイオテクノロジー
背景:
- CAR-T細胞治療は,血液がんに対して有効ですが,免疫抑制性腫瘍の微小環境と細胞の不十分な浸透により,固体腫瘍に対して限られています.
- マクロファージは,固有の腫瘍ホーミング,ファゴサイト,および抗原プレゼンテーション能力を有しており,固体腫瘍の免疫療法には魅力的です.
研究 の 目的:
- 固体腫瘍に対するCAR-マクロファージ (CAR-M) 免疫療法の包括的な概要を提供するために.
- CAR設計,マクロファージ工学,および臨床前/臨床の進展の進展をレビューする.
- CAR-M療法のメカニズム的洞察,利点,限界,そして将来の方向性について議論する.
主な方法:
- CAR-M免疫療法の開発と進歩に関する現在の文献のレビュー.
- CAR設計戦略とマクロファージエンジニアリング技術の分析.
- CAR-Mの抗腫瘍活性に関する臨床前および臨床データの検討.
主要な成果:
- CAR-M免疫療法は,マクロファージの機能を活用して,固い腫瘍の障壁を克服します.
- CAR設計とマクロファージ工学の進歩は,治療の可能性を高めています.
- 臨床前および臨床研究は有望な結果を示しているが,細胞の調達,耐久性,安全性に関する課題は依然として残っている.
結論:
- CAR-M免疫療法は,固体腫瘍を標的とする新しい有望な戦略を提示しています.
- 課題に対処し,革新的な戦略を実装することは,CAR-Mの有効性を最適化するために不可欠です.
- CAR-M療法は,がん免疫療法の将来において重要な役割を果たす準備が整っています.
関連する概念動画
01:27Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
01:26Targets for Drug Action: Overview
10.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.5K
01:22Target Cell Response to Hormones
5.8K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.8K
01:29Pharmacogenomics: Identification of New Drug Targets
3
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
3
01:24Modified-Release Drug Delivery Systems: Site-Targeted
4
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
4